Literature DB >> 1814735

The effect of food and metoclopramide on the pharmacokinetics and side effects of bromocriptine.

Z Kopitar1, B Vrhovac, L Povsic, F Plavsić, I Francetić, J Urbancic.   

Abstract

The effect of food and metoclopramide on the pharmacokinetics of bromocriptine was investigated in 7 healthy subjects. Plasma concentrations of bromocriptine were measured by radioimmunoassay after a single oral dose of 7.5 mg bromocriptine. Maximal plasma concentrations of bromocriptine were slightly lower when the drug was given after breakfast. Bioavailability of the drug was not significantly reduced by food nor by metoclopramide pre-treatment. Side effects of bromocriptine were considerably reduced by metoclopramide pre-treatment (0.5 mg/kg); the decrease was about 83% as estimated from Table II.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1814735     DOI: 10.1007/BF03189956

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  7 in total

1.  Adverse drug reactions. A critical review.

Authors:  F E Karch; L Lasagna
Journal:  JAMA       Date:  1975-12-22       Impact factor: 56.272

Review 2.  Bromocriptine in the treatment of acromegaly.

Authors:  D E Bateman; W M Tunbridge
Journal:  Drugs       Date:  1979-05       Impact factor: 9.546

3.  Triple stage quadrupole mass spectrometric determination of bromocriptine in human plasma with negative ion chemical ionization.

Authors:  N Häring; Z Salama; H Jaeger
Journal:  Arzneimittelforschung       Date:  1988-10

Review 4.  Interactions affecting drug absorption.

Authors:  P G Welling
Journal:  Clin Pharmacokinet       Date:  1984 Sep-Oct       Impact factor: 6.447

5.  Long-term ambulatory gastric pH monitoring: validation of a new method and effect of H2-antagonists.

Authors:  C J Fimmel; A Etienne; T Cilluffo; C von Ritter; T Gasser; J P Rey; P Caradonna-Moscatelli; F Sabbatini; F Pace; H W Bühler
Journal:  Gastroenterology       Date:  1985-06       Impact factor: 22.682

6.  Plasma bromocriptine levels, clinical and growth hormone responses in Parkinsonism.

Authors:  P Price; A Debono; J D Parkes; C D Marsden; J Rosenthaler
Journal:  Br J Clin Pharmacol       Date:  1978-10       Impact factor: 4.335

7.  Pharmacokinetics of bromocriptine during continuous oral treatment of Parkinson's disease.

Authors:  M L Friis; U Grøn; N E Larsen; H Pakkenberg; E F Hvidberg
Journal:  Eur J Clin Pharmacol       Date:  1979-05-21       Impact factor: 2.953

  7 in total
  3 in total

1.  Predicting effect of food on extent of drug absorption based on physicochemical properties.

Authors:  Chong-Hui Gu; Hua Li; Jaquan Levons; Kimberley Lentz; Rajesh B Gandhi; Krishnaswamy Raghavan; Ronald L Smith
Journal:  Pharm Res       Date:  2007-03-24       Impact factor: 4.200

Review 2.  Effects of food on clinical pharmacokinetics.

Authors:  B N Singh
Journal:  Clin Pharmacokinet       Date:  1999-09       Impact factor: 6.447

Review 3.  Pharmacokinetic optimisation in the treatment of Parkinson's disease.

Authors:  M Contin; R Riva; F Albani; A Baruzzi
Journal:  Clin Pharmacokinet       Date:  1996-06       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.